Literature DB >> 10397532

HIV-specific cytotoxic T lymphocyte precursors exist in a CD28-CD8+ T cell subset and increase with loss of CD4 T cells.

D E Lewis1, L Yang, W Luo, X Wang, J R Rodgers.   

Abstract

OBJECTIVES: To determine whether the CD28-CD8+ T cells that develop during HIV infection contain HIV-specific cytotoxic precursor cells.
DESIGN: CD8 subpopulations from six asymptomatic HIV-positive adults, with varying degrees of CD4 T cell loss, were sorted by flow cytometry and HIV-specific precursor cytotoxic T lymphocyte frequencies were measured. Three populations of CD8 T cells were tested: CD28+CD5-- T cells, CD28-CD57+ T cells (thought to be memory cells) and CD28-CD57- T cells (function unknown).
METHODS: Sorted CD8 subsets were stimulated with antigen presenting cells expressing HIV-1 Gag/Pol molecules. Cytotoxic T cell assays on Gag/Pol expressing 51Cr-labeled Epstein-Barr virus transformed autologous B cells lines or control targets were performed after 2 weeks. Specific lysis and precursor frequencies were calculated.
RESULTS: Both CD28 positive and CD28-CD57+ populations contained appreciable numbers of precursors (9-1720 per 10(6) CD8+ T cells). However, the CD28-CD57- population had fewer precursors in five out of six people studied. More CD28 positive HIV-specific cytotoxic T lymphocyte precursors were found in patients with CD4:CD8 ratios > 1, whereas more CD28-CD57+ precursors were found in patients whose CD4:CD8 ratios were < 1 (r2, 0.68).
CONCLUSIONS: Memory HIV-specific precursor cytotoxic T lymphocytes are found in both CD28 positive and CD28-CD8+ cells, however, a CD28-CD57- subpopulation had fewer. Because CD28-CD57+ cells are antigen-driven with limited diversity, the loss of CD28 on CD8 T cells during disease progression may reduce the response to new HIV mutations; this requires further testing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397532     DOI: 10.1097/00002030-199906180-00005

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  9 in total

Review 1.  Aging, cytomegalovirus (CMV) and influenza vaccine responses.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 2.  Inflammaging decreases adaptive and innate immune responses in mice and humans.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Biogerontology       Date:  2015-04-29       Impact factor: 4.277

3.  Adenosine deaminase modulation of telomerase activity and replicative senescence in human CD8 T lymphocytes.

Authors:  Stanley T Parish; Sarah Kim; Rekha K Sekhon; Jennifer E Wu; Yukako Kawakatsu; Rita B Effros
Journal:  J Immunol       Date:  2010-02-10       Impact factor: 5.422

4.  Differential dynamics of CD4(+) and CD8(+) T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection.

Authors:  A Kaur; C L Hale; S Ramanujan; R K Jain; R P Johnson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3.

Authors:  Stanley T Parish; Jennifer E Wu; Rita B Effros
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

6.  CD8beta/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes.

Authors:  S Werwitzke; A Tiede; B E Drescher; R E Schmidt; T Witte
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

7.  Premature aging of T cells is associated with faster HIV-1 disease progression.

Authors:  Weiwei Cao; Beth D Jamieson; Lance E Hultin; Patricia M Hultin; Rita B Effros; Roger Detels
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

Review 8.  Dynamics of T cell memory in human cytomegalovirus infection.

Authors:  Edward C P Waller; Elizabeth Day; J G Patrick Sissons; Mark R Wills
Journal:  Med Microbiol Immunol       Date:  2008-02-27       Impact factor: 3.402

9.  Immune reconstitution and viral stimulation are required to restore HIV-specific CD8 T cell responses following advanced infection.

Authors:  Jane Gamberg; Lisa Barrett; Ian Bowmer; Constance Howley; Michael Grant
Journal:  J Clin Immunol       Date:  2004-03       Impact factor: 8.542

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.